Tracon Pharmaceuticals, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q3 2016 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Tracon Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2016 to Q2 2024.
  • Tracon Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 3.01M shares, a 88.5% increase year-over-year.
  • Tracon Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 32.7M shares, a 56.5% increase from 2022.
  • Tracon Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 20.9M shares, a 21.3% increase from 2021.
  • Tracon Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 17.3M shares, a 92% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 3.01M +1.41M +88.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 2.39M +1.13M +89.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 32.7M +11.8M +56.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-05
Q3 2023 36.9M +15.4M +71.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 1.6M -18.7M -92.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 1.26M -18.4M -93.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 20.9M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-05
Q3 2022 21.5M +2.94M +15.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 20.3M +4.77M +30.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 19.6M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q3 2021 18.5M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 15.5M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q3 2018 29.8M +12.7M +74.1% Jul 1, 2018 Sep 30, 2018 10-Q 2018-11-07
Q3 2017 17.1M +4.91M +40.2% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q3 2016 12.2M Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.